Objective: Disease progression is a strong indicator of treatment for Mycobacterium avium complex lung disease (MAC-LD). The impact of MAC subspecies on the risk of disease progression remains uncertain in MAC-LD patients.Pan, S-WShu, C-CFeng, J-YChien, J-YWang, J-YChan, Y-JYu, C-...
Pulmonary manifestations in RA encompass a wide spectrum of conditions, commonly classified into interstitial lung disease associated with RA (RA-ILD) and non-RA-ILD manifestations [14, 15]. RA-ILD is a chronic and often progressive pulmonary complication frequently encountered in patients with RA ...
The failure of all miRNA to return to baseline levels may reflect ongoing remodelling in the lung parenchyma that continues after completion of anti-TB therapy.关键词: Tuberculosis Biomarker Plasma miRNA Anti-mycobacterial therapy Disease progression ...
Recently, using the National Heart, Lung, and Blood Institute (NHLBI) dynamic registry including high-risk patients, Abbott et al. (13) reported that adjusted 1-year outcomes in BMS and DES were independent of sex. However, the impact of sex on long-term outcome in unselected patients after...
doi:10.1007/s12105-018-0920-8Watson, MelanieMcAllister, PeterConn, BrendanMacNeill, MornaHandley, Thomas P. B.Springer USHead & Neck Pathology
Objectives Disease progression is a strong indicator of treatment for Mycobacterium avium complex-lung disease (MAC-LD). The impact of MAC subspecies on the risk of disease progression remains uncertain in MAC-LD patients. Methods In this cohort study, we included MAC-LD patients from 2013 to ...